Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Avelas Biosciences Inc Provider of advance, new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons. |
United States | 18 Aug 2016 | Series C Round participant. Active |
|
|
Nutrinia Ltd Developer of an oral formulation of insulin for intestinal malabsorption in preterm newborns and SBS in infants. |
Israel | 18 Aug 2016 | Series D Initial investment. Round participant. Active |